{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:58:15Z","timestamp":1791086295183,"version":"4.1.0"},"reference-count":262,"publisher":"European Respiratory Society (ERS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2010,10,4]]},"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>In many parts of the world the commonest serious opportunistic infection that occurs in HIV-1 infected persons is tuberculosis (TB). HIV-1 co-infection modifies the natural history and clinical presentation, and adversely affects the outcome of TB. Severe disseminated disease is well-recognised but it is increasingly appreciated that early disease characterised by very few or no symptoms is also common. Immunodiagnostic methods to ascertain latent TB in HIV-1 infected persons are compromised in sensitivity.<\/jats:p><jats:p>Chemoprevention of HIV-1-associated TB is effective, its benefits are restricted to those which have evidence of immune sensitisation and appear short-lived in areas of high TB burden. Although promising advances in the microbiological diagnosis of TB have recently occurred, the diagnosis of HIV-1-associated TB remains difficult because of more frequent presentation as sputum negative or extrapulmonary disease.<\/jats:p><jats:p>Management of co-infected patients can be complex because of overlapping drug toxicities and interactions. Nevertheless consensus is developing that antiretroviral therapy should be provided as soon as practicable after starting TB treatment in HIV-1 co-infected persons. This has the consequence of increasing the frequency of immune reconstitution inflammatory syndrome, the pathogenesis and management of which is poorly defined.<\/jats:p>","DOI":"10.1183\/09031936.00110210","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T00:55:05Z","timestamp":1287104105000},"page":"1460-1481","source":"Crossref","is-referenced-by-count":63,"title":["Clinical management of tuberculosis and HIV-1 co-infection"],"prefix":"10.1183","volume":"36","author":[{"given":"C.","family":"Schutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Almajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"2024102020275345000_36.6.1460.1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","article-title":"Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis","volume":"23","author":"Wood","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024102020275345000_36.6.1460.2","doi-asserted-by":"publisher","DOI":"10.1053\/S0882-0546(03)00072-0"},{"key":"2024102020275345000_36.6.1460.3","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91346-N"},{"key":"2024102020275345000_36.6.1460.4","doi-asserted-by":"publisher","DOI":"10.1086\/426827"},{"key":"2024102020275345000_36.6.1460.5","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.3.540"},{"key":"2024102020275345000_36.6.1460.6","doi-asserted-by":"publisher","DOI":"10.1097\/00063198-200105000-00003"},{"key":"2024102020275345000_36.6.1460.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.5.1292"},{"key":"2024102020275345000_36.6.1460.8","first-page":"515","article-title":"HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment","volume":"70","author":"Raviglione","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2024102020275345000_36.6.1460.9","first-page":"651","article-title":"An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa","volume":"76","author":"Harries","year":"1998","journal-title":"Bull World Health Organ"},{"key":"2024102020275345000_36.6.1460.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200907-0989OC"},{"key":"2024102020275345000_36.6.1460.11","first-page":"413","article-title":"High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000\u20132003","volume":"14","author":"Brust","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.12","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080025"},{"key":"2024102020275345000_36.6.1460.13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/ajrccm\/146.1.53","article-title":"Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation","volume":"146","author":"Batungwanayo","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2024102020275345000_36.6.1460.14","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199808000-00011"},{"key":"2024102020275345000_36.6.1460.15","first-page":"116","article-title":"Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and -uninfected adults at a teaching hospital, northwest Ethiopia","volume":"40","author":"Kassu","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"2024102020275345000_36.6.1460.16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1590\/S0037-86822007000600004","article-title":"Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression","volume":"40","author":"Garcia","year":"2007","journal-title":"Rev Soc Bras Med Trop"},{"key":"2024102020275345000_36.6.1460.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)90727-1"},{"key":"2024102020275345000_36.6.1460.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907488"},{"key":"2024102020275345000_36.6.1460.19","doi-asserted-by":"publisher","DOI":"10.1086\/429825"},{"key":"2024102020275345000_36.6.1460.20","first-page":"896","article-title":"Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful tool","volume":"8","author":"Swaminathan","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200606-759OC"},{"key":"2024102020275345000_36.6.1460.22","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832e05c8"},{"key":"2024102020275345000_36.6.1460.23","doi-asserted-by":"publisher","DOI":"10.1086\/656282"},{"key":"2024102020275345000_36.6.1460.24","doi-asserted-by":"publisher","DOI":"10.1086\/518664"},{"key":"2024102020275345000_36.6.1460.25","first-page":"159","article-title":"Clinical profile of tuberculosis in patients with HIV Infection\/AIDS","volume":"44","author":"Kumar","year":"2002","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"2024102020275345000_36.6.1460.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70043-X"},{"key":"2024102020275345000_36.6.1460.27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/ajrccm\/136.3.570","article-title":"Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival","volume":"136","author":"Chaisson","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2024102020275345000_36.6.1460.28","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/24.4.661"},{"key":"2024102020275345000_36.6.1460.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6943.1531"},{"key":"2024102020275345000_36.6.1460.30","first-page":"1","article-title":"The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia","volume":"96","author":"Elliott","year":"1993","journal-title":"J Trop Med Hyg"},{"key":"2024102020275345000_36.6.1460.31","first-page":"316","article-title":"Extrapulmonary tuberculosis","volume":"120","author":"Sharma","year":"2004","journal-title":"Indian J Med Res"},{"key":"2024102020275345000_36.6.1460.32","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110026511"},{"key":"2024102020275345000_36.6.1460.33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-44"},{"key":"2024102020275345000_36.6.1460.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12325-5"},{"key":"2024102020275345000_36.6.1460.35","first-page":"220","article-title":"Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis","volume":"9","author":"Wilson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.36","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.5.1164"},{"key":"2024102020275345000_36.6.1460.37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/00365549409008598","article-title":"AIDS presenting as septic shock caused by Mycobacterium tuberculosis","volume":"26","author":"Vadillo","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"2024102020275345000_36.6.1460.38","first-page":"31","article-title":"Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults","volume":"10","author":"Wilson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.08.012"},{"key":"2024102020275345000_36.6.1460.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203053261004"},{"key":"2024102020275345000_36.6.1460.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-005X(06)73770-3"},{"key":"2024102020275345000_36.6.1460.42","doi-asserted-by":"publisher","DOI":"10.1086\/498220"},{"key":"2024102020275345000_36.6.1460.43","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.11.743"},{"key":"2024102020275345000_36.6.1460.44","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440140144014"},{"key":"2024102020275345000_36.6.1460.45","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0296-0"},{"key":"2024102020275345000_36.6.1460.46","doi-asserted-by":"publisher","DOI":"10.1086\/376987"},{"key":"2024102020275345000_36.6.1460.47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002253"},{"key":"2024102020275345000_36.6.1460.48","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-590OC"},{"key":"2024102020275345000_36.6.1460.49","first-page":"1231","article-title":"Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control","volume":"13","author":"Corbett","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.50","first-page":"1308","article-title":"TB presenting as community-acquired pneumonia in a setting of high TB incidence and high HIV prevalence","volume":"11","author":"Nyamande","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.51","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328333850f"},{"key":"2024102020275345000_36.6.1460.52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00042560-200005010-00004","article-title":"Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya","volume":"24","author":"Rana","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024102020275345000_36.6.1460.53","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/ajrccm.159.3.9804147","article-title":"Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients","volume":"159","author":"Murray","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020275345000_36.6.1460.54","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181b31e56"},{"key":"2024102020275345000_36.6.1460.55","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90668-1"},{"key":"2024102020275345000_36.6.1460.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2009.02.005"},{"key":"2024102020275345000_36.6.1460.57","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2236"},{"key":"2024102020275345000_36.6.1460.58","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00120908"},{"key":"2024102020275345000_36.6.1460.59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040022"},{"key":"2024102020275345000_36.6.1460.60","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91474-Z"},{"key":"2024102020275345000_36.6.1460.61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903023200901"},{"key":"2024102020275345000_36.6.1460.62","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131336.15301.06"},{"key":"2024102020275345000_36.6.1460.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406163302403"},{"key":"2024102020275345000_36.6.1460.64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61262-8"},{"key":"2024102020275345000_36.6.1460.65","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480030047035"},{"key":"2024102020275345000_36.6.1460.66","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490040080029"},{"key":"2024102020275345000_36.6.1460.67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-119-3-199308010-00002","article-title":"Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary complications of HIV Infection Study Group","volume":"119","author":"Markowitz","year":"1993","journal-title":"Ann Intern Med"},{"key":"2024102020275345000_36.6.1460.68","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200610-1439OC"},{"key":"2024102020275345000_36.6.1460.69","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/iai.63.5.1710-1717.1995","article-title":"Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis","volume":"63","author":"Sorensen","year":"1995","journal-title":"Infect Immun"},{"key":"2024102020275345000_36.6.1460.70","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-11-3195"},{"key":"2024102020275345000_36.6.1460.71","doi-asserted-by":"publisher","DOI":"10.1086\/381679"},{"key":"2024102020275345000_36.6.1460.72","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1704OC"},{"key":"2024102020275345000_36.6.1460.73","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"2024102020275345000_36.6.1460.74","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00171509"},{"key":"2024102020275345000_36.6.1460.75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.5217"},{"key":"2024102020275345000_36.6.1460.76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.9.6353"},{"key":"2024102020275345000_36.6.1460.77","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.3026-3032.2002"},{"key":"2024102020275345000_36.6.1460.78","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-23"},{"key":"2024102020275345000_36.6.1460.79","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00045509"},{"key":"2024102020275345000_36.6.1460.80","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00191809"},{"key":"2024102020275345000_36.6.1460.81","doi-asserted-by":"publisher","DOI":"10.1086\/597351"},{"key":"2024102020275345000_36.6.1460.82","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-56"},{"key":"2024102020275345000_36.6.1460.83","first-page":"1190","article-title":"Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals","volume":"11","author":"Jones","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.84","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1088OC"},{"key":"2024102020275345000_36.6.1460.85","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2575"},{"key":"2024102020275345000_36.6.1460.86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-15"},{"key":"2024102020275345000_36.6.1460.87","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283188415"},{"issue":"Suppl. 2","key":"2024102020275345000_36.6.1460.88","first-page":"S182","article-title":"New diagnostic tools for tuberculosis","volume":"4","author":"Perkins","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.89","first-page":"692","article-title":"Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi","volume":"12","author":"Yu","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.90","doi-asserted-by":"publisher","DOI":"10.1086\/514546"},{"key":"2024102020275345000_36.6.1460.91","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03406-0"},{"key":"2024102020275345000_36.6.1460.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101313240503"},{"key":"2024102020275345000_36.6.1460.93","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.4.772"},{"key":"2024102020275345000_36.6.1460.94","first-page":"791","article-title":"Mycobacterial disease in South African gold miners in the era of HIV infection","volume":"3","author":"Churchyard","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0962-8479(94)90098-1","article-title":"The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis","volume":"75","author":"Nunn","year":"1994","journal-title":"Tuber Lung Dis"},{"key":"2024102020275345000_36.6.1460.96","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.3.684"},{"key":"2024102020275345000_36.6.1460.97","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.4.849"},{"key":"2024102020275345000_36.6.1460.98","doi-asserted-by":"publisher","DOI":"10.1378\/chest.99.1.123"},{"key":"2024102020275345000_36.6.1460.99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1164\/ajrccm\/143.1.69","article-title":"Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti","volume":"143","author":"Long","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2024102020275345000_36.6.1460.100","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2105\/AJPH.81.10.1326","article-title":"The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis","volume":"81","author":"Long","year":"1991","journal-title":"Am J Public Health"},{"key":"2024102020275345000_36.6.1460.101","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6749.412"},{"key":"2024102020275345000_36.6.1460.102","doi-asserted-by":"publisher","DOI":"10.1378\/chest.95.6.1190"},{"key":"2024102020275345000_36.6.1460.103","first-page":"189","article-title":"Recent advances in the diagnosis and management of tuberculosis","volume":"11","author":"Furin","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"2024102020275345000_36.6.1460.104","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70578-3"},{"key":"2024102020275345000_36.6.1460.105","doi-asserted-by":"publisher","DOI":"10.1086\/589248"},{"key":"2024102020275345000_36.6.1460.106","first-page":"276","article-title":"Sputum induction with heated aerosol inhalations for the diagnosis of tuberculosis","volume":"84","author":"Lillehei","year":"1961","journal-title":"Am Rev Respir Dis"},{"key":"2024102020275345000_36.6.1460.107","first-page":"455","article-title":"Suspected pulmonary tuberculosis in rural South Africa: sputum induction as a simple diagnostic tool?","volume":"92","author":"Hartung","year":"2002","journal-title":"S Afr Med J"},{"key":"2024102020275345000_36.6.1460.108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0962-8479(95)90583-9","article-title":"The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi","volume":"76","author":"Parry","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"2024102020275345000_36.6.1460.109","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(95)90527-8"},{"key":"2024102020275345000_36.6.1460.110","unstructured":"World Health Organization . Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource constrained settings. Geneva, World Health Organizationwww.who.int\/tb\/publications\/2006\/tbhiv_recommendations.pdf , 2006."},{"key":"2024102020275345000_36.6.1460.111","first-page":"97","article-title":"A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis","volume":"4","author":"Colebunders","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.112","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00609-1"},{"key":"2024102020275345000_36.6.1460.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.09.015"},{"key":"2024102020275345000_36.6.1460.114","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.38.11.4167-4170.2000","article-title":"Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria","volume":"38","author":"Williams-Bouyer","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2024102020275345000_36.6.1460.115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.38.3.1203-1208.2000","article-title":"Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru","volume":"38","author":"Caviedes","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2024102020275345000_36.6.1460.116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001173"},{"key":"2024102020275345000_36.6.1460.117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055524"},{"key":"2024102020275345000_36.6.1460.118","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-5-55"},{"key":"2024102020275345000_36.6.1460.119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001536"},{"key":"2024102020275345000_36.6.1460.120","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01463-09"},{"key":"2024102020275345000_36.6.1460.121","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00061808"},{"key":"2024102020275345000_36.6.1460.122","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211220-00008"},{"key":"2024102020275345000_36.6.1460.123","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-35"},{"key":"2024102020275345000_36.6.1460.124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-75"},{"key":"2024102020275345000_36.6.1460.125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002489"},{"key":"2024102020275345000_36.6.1460.126","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4314\/eamj.v85i9.117085","article-title":"Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients","volume":"85","author":"Seshadri","year":"2008","journal-title":"East Afr Med J"},{"key":"2024102020275345000_36.6.1460.127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005718"},{"key":"2024102020275345000_36.6.1460.128","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02411-05"},{"key":"2024102020275345000_36.6.1460.129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03477.x"},{"key":"2024102020275345000_36.6.1460.130","doi-asserted-by":"publisher","DOI":"10.1086\/518234"},{"key":"2024102020275345000_36.6.1460.131","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00355-08"},{"key":"2024102020275345000_36.6.1460.132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040202"},{"key":"2024102020275345000_36.6.1460.133","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/ajrccm.154.4.8887603","article-title":"Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection","volume":"154","author":"Chaisson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020275345000_36.6.1460.134","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910010-00012"},{"key":"2024102020275345000_36.6.1460.135","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00002030-199510000-00011","article-title":"Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa","volume":"9","author":"Kassim","year":"1995","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.136","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1529OC"},{"key":"2024102020275345000_36.6.1460.137","doi-asserted-by":"publisher","DOI":"10.1086\/318706"},{"key":"2024102020275345000_36.6.1460.138","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328311ac4e"},{"key":"2024102020275345000_36.6.1460.139","doi-asserted-by":"publisher","DOI":"10.1086\/520275"},{"key":"2024102020275345000_36.6.1460.140","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.7.536"},{"key":"2024102020275345000_36.6.1460.141","doi-asserted-by":"publisher","DOI":"10.1086\/651686"},{"key":"2024102020275345000_36.6.1460.142","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00186409"},{"key":"2024102020275345000_36.6.1460.143","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70041-6"},{"key":"2024102020275345000_36.6.1460.144","first-page":"1145","article-title":"Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy)","volume":"79","author":"Farmer","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2024102020275345000_36.6.1460.145","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199408000-00010"},{"key":"2024102020275345000_36.6.1460.146","unstructured":"Swaminathan S Narendran G Venkatesan P . Acquired rifampicin resistance in HIV-infected and -uninfected patients with TB treated with a thrice-weekly short-course regimen. Abstract 783. 16th Conference on Retrovirusses and Opportunistic Infections, Montreal, Canada, 2009."},{"key":"2024102020275345000_36.6.1460.147","first-page":"214","article-title":"Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024102020275345000_36.6.1460.148","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11467-8"},{"key":"2024102020275345000_36.6.1460.149","doi-asserted-by":"publisher","DOI":"10.1086\/381675"},{"key":"2024102020275345000_36.6.1460.150","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-417OC"},{"key":"2024102020275345000_36.6.1460.151","doi-asserted-by":"publisher","DOI":"10.1086\/427995"},{"key":"2024102020275345000_36.6.1460.152","doi-asserted-by":"publisher","DOI":"10.1086\/422257"},{"key":"2024102020275345000_36.6.1460.153","doi-asserted-by":"publisher","DOI":"10.1136\/heart.84.2.183"},{"key":"2024102020275345000_36.6.1460.154","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040573"},{"key":"2024102020275345000_36.6.1460.155","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002244.pub3"},{"key":"2024102020275345000_36.6.1460.156","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(97)00071-9"},{"key":"2024102020275345000_36.6.1460.157","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3565(24)29202-8","article-title":"Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays","volume":"299","author":"Rae","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"2024102020275345000_36.6.1460.158","doi-asserted-by":"publisher","DOI":"10.1007\/BF00615223"},{"key":"2024102020275345000_36.6.1460.159","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1455"},{"key":"2024102020275345000_36.6.1460.160","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.9.4001"},{"key":"2024102020275345000_36.6.1460.161","first-page":"CD005159","article-title":"Rifabutin for treating pulmonary tuberculosis","volume":"4","author":"Davies","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102020275345000_36.6.1460.162","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(94)90079-5"},{"key":"2024102020275345000_36.6.1460.163","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.5.8912765"},{"key":"2024102020275345000_36.6.1460.164","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(05)80007-3"},{"key":"2024102020275345000_36.6.1460.165","doi-asserted-by":"publisher","DOI":"10.1086\/313771"},{"key":"2024102020275345000_36.6.1460.166","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241090-00004"},{"key":"2024102020275345000_36.6.1460.167","unstructured":"Soy D Lopez E Sarasa M . Population pharmacokinetic modeling in HIV patients with tuberculosis treated with efavirenz and rifampicin. Abstract 15. 6th International Workshop on Clinical Pharmacology of HIV Therapy, Quebec City, Canada, 2005."},{"key":"2024102020275345000_36.6.1460.168","doi-asserted-by":"publisher","DOI":"10.2174\/157016207780636588"},{"key":"2024102020275345000_36.6.1460.169","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000196181.18916.9b"},{"key":"2024102020275345000_36.6.1460.170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S1413-86702004000300004","article-title":"Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis","volume":"8","author":"Pedral-Sampaio","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"2024102020275345000_36.6.1460.171","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-11-S1-O9"},{"key":"2024102020275345000_36.6.1460.172","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.530"},{"key":"2024102020275345000_36.6.1460.173","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00492-09"},{"key":"2024102020275345000_36.6.1460.174","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl399"},{"key":"2024102020275345000_36.6.1460.175","doi-asserted-by":"publisher","DOI":"10.1086\/650539"},{"key":"2024102020275345000_36.6.1460.176","doi-asserted-by":"publisher","DOI":"10.1086\/499364"},{"key":"2024102020275345000_36.6.1460.177","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183519.45137.a6"},{"key":"2024102020275345000_36.6.1460.178","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3283339309"},{"key":"2024102020275345000_36.6.1460.179","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00002030-200303070-00024","article-title":"Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis","volume":"17","author":"Oliva","year":"2003","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.180","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200112150-00007"},{"key":"2024102020275345000_36.6.1460.181","doi-asserted-by":"crossref","unstructured":"Robinson P Lamson M Gigliotti M . Pharmacokinetic interaction between nevirapine and rifampicin. Abstract 60623. 12th World AIDS conference, Geneva, Switzerland, 1998.","DOI":"10.1097\/00002030-199810000-00017"},{"key":"2024102020275345000_36.6.1460.182","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/135965350501000809","article-title":"Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis","volume":"10","author":"Autar","year":"2005","journal-title":"Antivir Ther"},{"key":"2024102020275345000_36.6.1460.183","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm484"},{"key":"2024102020275345000_36.6.1460.184","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/135965350801300414","article-title":"Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin","volume":"13","author":"Avihingsanon","year":"2008","journal-title":"Antivir Ther"},{"key":"2024102020275345000_36.6.1460.185","unstructured":"Van Cutsem G Cohen K Bedelu M . TB\/HIV co-infected patients on rifampicin containing treatment have equivalent ART treatment outcomes, and concurrent use of nevirapine is not associated with increase in hepatotoxicity. Abstract WePp0303. 3rd Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 2005."},{"key":"2024102020275345000_36.6.1460.186","unstructured":"Van Heeswijk R Hoetelmans R Kestens D . The effects of CYP3A4 modulation on the pharmacokinetics of TMC278, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI). Abstract 74. 7th International Workshop on Clinical Pharmacology of HIV Therapy Lisbon, Portugal, 2006."},{"key":"2024102020275345000_36.6.1460.187","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1553-1560.2004"},{"key":"2024102020275345000_36.6.1460.188","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282faa71e"},{"key":"2024102020275345000_36.6.1460.189","doi-asserted-by":"publisher","DOI":"10.1086\/313548"},{"key":"2024102020275345000_36.6.1460.190","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182629.74336.4d"},{"key":"2024102020275345000_36.6.1460.191","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl552"},{"key":"2024102020275345000_36.6.1460.192","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-5174.2009.00017.x"},{"key":"2024102020275345000_36.6.1460.193","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-07"},{"key":"2024102020275345000_36.6.1460.194","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-06"},{"key":"2024102020275345000_36.6.1460.195","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00442.x"},{"key":"2024102020275345000_36.6.1460.196","unstructured":"Boehringer Ingelheim Pharmaceuticals Inc . AptivusR package insert. 2005"},{"key":"2024102020275345000_36.6.1460.197","doi-asserted-by":"publisher","DOI":"10.1086\/606056"},{"key":"2024102020275345000_36.6.1460.198","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/QAD.0b013e328329148e","article-title":"Clinical experience with the combined use of lopinavir\/ritonavir and rifampicin","volume":"23","author":"L'Homme R","year":"2009","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.199","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.aids.0000233572.59522.45","article-title":"Virological response to a triple nucleoside\/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa","volume":"20","author":"DART Virology Trial Team","year":"2006","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.aids.0000233572.59522.45","article-title":"Virological response to a triple nucleoside\/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa","volume":"20","year":"2006","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.201","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32823ecf6e"},{"key":"2024102020275345000_36.6.1460.202","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031772"},{"key":"2024102020275345000_36.6.1460.203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/QAD.0b013e3283294a04","article-title":"The utility of nucleos(t)ide-only regimens in the treatment of Mycobacterium tuberculosis-HIV-1 coinfection","volume":"23","author":"Armstrong-James","year":"2009","journal-title":"AIDS"},{"key":"2024102020275345000_36.6.1460.204","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01468-08"},{"key":"2024102020275345000_36.6.1460.205","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03134.x"},{"key":"2024102020275345000_36.6.1460.206","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544020-00003"},{"key":"2024102020275345000_36.6.1460.207","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17141-9"},{"key":"2024102020275345000_36.6.1460.208","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90693-9"},{"key":"2024102020275345000_36.6.1460.209","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328326ca50"},{"key":"2024102020275345000_36.6.1460.210","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200206-626OC"},{"key":"2024102020275345000_36.6.1460.211","first-page":"197","article-title":"Risk factors for hepatotoxicity induced by antituberculosis drugs","volume":"47","author":"Devoto","year":"1997","journal-title":"Acta Physiol Pharmacol Ther Latinoam"},{"key":"2024102020275345000_36.6.1460.212","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201040-00010"},{"key":"2024102020275345000_36.6.1460.213","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.058867"},{"key":"2024102020275345000_36.6.1460.214","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003310-00017"},{"key":"2024102020275345000_36.6.1460.215","doi-asserted-by":"publisher","DOI":"10.1086\/598977"},{"key":"2024102020275345000_36.6.1460.216","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01173-7.x"},{"key":"2024102020275345000_36.6.1460.217","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00202170","article-title":"Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety","volume":"48","author":"Galloe","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"2024102020275345000_36.6.1460.218","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283262a64"},{"key":"2024102020275345000_36.6.1460.219","doi-asserted-by":"publisher","DOI":"10.1086\/518658"},{"key":"2024102020275345000_36.6.1460.220","first-page":"705","article-title":"Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis","volume":"4","author":"Churchyard","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.221","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905848"},{"key":"2024102020275345000_36.6.1460.222","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328011efac"},{"key":"2024102020275345000_36.6.1460.223","doi-asserted-by":"crossref","unstructured":"Blanc FX Sok T Laureillard D . Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis. Abstract THLBB106. 18th International AIDS Conference, Vienna, Austria, 2010.","DOI":"10.1186\/1753-6561-5-S1-O11"},{"key":"2024102020275345000_36.6.1460.224","unstructured":"Torok M Yen N Chau T . Randomised controlled trial of immediated versus deferred antiretroviral therapy in HIV-associated tuberculosis meningitis. Abstract H-1224. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, United States of America, 2009."},{"key":"2024102020275345000_36.6.1460.225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/ajrccm.164.1.2101133","article-title":"Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy","volume":"164","author":"Burman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020275345000_36.6.1460.226","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.4.603"},{"key":"2024102020275345000_36.6.1460.227","unstructured":"Moreno S . Antiviral therapy and tuberculosis, Abstract TuOr171. 14th World AIDS Conference, Barcelona, Spain, 2002."},{"key":"2024102020275345000_36.6.1460.228","unstructured":"Navas E Oliva J Miralles P . Antiretroviral therapy in AIDS patient. Abstract ThPeB7271. 14th World AIDS Conference, Barcelona, Spain, 2002."},{"key":"2024102020275345000_36.6.1460.229","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131375.21070.06"},{"key":"2024102020275345000_36.6.1460.230","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-009-0022-z"},{"key":"2024102020275345000_36.6.1460.231","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70184-1"},{"key":"2024102020275345000_36.6.1460.232","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.1.9712001"},{"key":"2024102020275345000_36.6.1460.233","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.019224"},{"key":"2024102020275345000_36.6.1460.234","doi-asserted-by":"publisher","DOI":"10.1086\/425742"},{"key":"2024102020275345000_36.6.1460.235","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.01.002"},{"key":"2024102020275345000_36.6.1460.236","doi-asserted-by":"publisher","DOI":"10.1086\/596764"},{"key":"2024102020275345000_36.6.1460.237","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832f7b59"},{"key":"2024102020275345000_36.6.1460.238","doi-asserted-by":"publisher","DOI":"10.1086\/598988"},{"key":"2024102020275345000_36.6.1460.239","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000161769.06158.8a"},{"key":"2024102020275345000_36.6.1460.240","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","article-title":"Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis","volume":"10","author":"Michailidis","year":"2005","journal-title":"Antivir Ther"},{"key":"2024102020275345000_36.6.1460.241","first-page":"1282","article-title":"Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis","volume":"11","author":"Burman","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102020275345000_36.6.1460.242","doi-asserted-by":"crossref","unstructured":"Haddow LJ Moosa MY Easterbrook PJ . Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS;24: 103\u2013108.","DOI":"10.1097\/QAD.0b013e32832ec1f4"},{"key":"2024102020275345000_36.6.1460.243","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833dfc68"},{"key":"2024102020275345000_36.6.1460.244","first-page":"855","article-title":"Use of prednisolone in the treatment of HIV-positive tuberculosis patients","volume":"85","author":"Elliott","year":"1992","journal-title":"Q J Med"},{"key":"2024102020275345000_36.6.1460.245","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f4f223"},{"key":"2024102020275345000_36.6.1460.246","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f09876"},{"key":"2024102020275345000_36.6.1460.247","doi-asserted-by":"publisher","DOI":"10.1086\/522986"},{"key":"2024102020275345000_36.6.1460.248","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1311PP"},{"key":"2024102020275345000_36.6.1460.249","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32831d2a98"},{"key":"2024102020275345000_36.6.1460.250","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.4.337"},{"key":"2024102020275345000_36.6.1460.251","doi-asserted-by":"publisher","DOI":"10.1086\/517636"},{"key":"2024102020275345000_36.6.1460.252","first-page":"363","article-title":"Immune reconstitution inflammatory syndrome manifesting as disseminated tuberculosis, deep venous thrombosis, encephalopathy and myelopathy","volume":"50","author":"Tahir","year":"2008","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"2024102020275345000_36.6.1460.253","doi-asserted-by":"crossref","unstructured":"Chen WL Lin YF Tsai WC . Unveiling tuberculous pyomyositis: an emerging role of immune reconstitution inflammatory syndrome. Am J Emerg Med 2009:27: e251\u2013e252.","DOI":"10.1016\/j.ajem.2008.05.030"},{"key":"2024102020275345000_36.6.1460.254","doi-asserted-by":"publisher","DOI":"10.1086\/597098"},{"key":"2024102020275345000_36.6.1460.255","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102020275345000_36.6.1460.256","doi-asserted-by":"publisher","DOI":"10.1086\/510080"},{"key":"2024102020275345000_36.6.1460.257","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70326-3"},{"key":"2024102020275345000_36.6.1460.258","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2024102020275345000_36.6.1460.259","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111090-00009"},{"key":"2024102020275345000_36.6.1460.260","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101260-00011"},{"key":"2024102020275345000_36.6.1460.261","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00014"},{"key":"2024102020275345000_36.6.1460.262","unstructured":"Samandari T . Randomized, placebo controlled trial of 6 vs 34 months of isoniazid TB preventative therapy for HIV-infected adults in Botswana. Paper #104LB. 17th Conference on Retrovirusses and Opportunistic Infections. San Francisco, USA, 2009."}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00110210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T20:09:26Z","timestamp":1740600566000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00110210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":262,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,11,30]]},"published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1183\/09031936.00110210"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00110210","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}